Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43664,1783,1.25 [1.16-1.35],3.0731045675591273e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,42975,432,1.90 [1.65-2.19],8.660422888944124e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,47733,326,1.12 [0.95-1.32],0.1923255781042239
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33034,1558,1.52 [1.40-1.65],1.585854301323425e-23
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47629,222,1.08 [0.88-1.32],0.478071809859231
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,44543,174,2.00 [1.62-2.47],8.103697852761316e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50091,220,1.07 [0.88-1.31],0.4985660993907004
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50097,151,0.97 [0.76-1.23],0.7796983613144961
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43507,117,1.42 [1.08-1.88],0.0135999318960333
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,48438,240,1.81 [1.51-2.18],1.8520782553576023e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,48353,155,1.91 [1.53-2.39],1.0103393594267125e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50262,133,0.92 [0.72-1.19],0.5426343564891689
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50248,162,0.94 [0.75-1.19],0.6287932552836625
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50237,151,0.91 [0.72-1.16],0.4464462747021933
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,49567,105,1.10 [0.82-1.47],0.5270627069157074
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",47835,814,1.34 [1.20-1.49],1.0105600891684493e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47304,283,1.47 [1.23-1.76],1.902403156934657e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,47576,555,1.32 [1.16-1.50],2.7172122364289528e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",40312,128,1.08 [0.82-1.41],0.5858275241970874
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40296,112,0.97 [0.73-1.30],0.8475130878444929
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",40703,519,1.10 [0.96-1.26],0.1714644562897712
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",40719,535,1.09 [0.96-1.25],0.188048482950942
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22791,663,1.03 [0.91-1.16],0.6144548130027692
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18286,230,1.06 [0.87-1.29],0.5578748865171281
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40286,102,1.14 [0.84-1.54],0.3971517569534264
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,44905,1559,1.41 [1.30-1.52],1.939989500741736e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",47729,657,1.08 [0.96-1.21],0.2217192313262939
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,49357,225,1.04 [0.86-1.27],0.6711446542709292
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50412,220,1.13 [0.92-1.38],0.2475514372002945
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,49862,130,1.32 [1.01-1.71],0.0389372340107424
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50427,131,1.05 [0.81-1.36],0.717578346170329
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Stomach,50519,100,0.88 [0.66-1.18],0.3984554057589275
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,49975,575,0.93 [0.82-1.05],0.2190968533270451
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50432,206,0.95 [0.77-1.16],0.6065270931722169
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50439,175,1.00 [0.80-1.26],0.9727373944152844
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50323,103,1.32 [0.98-1.78],0.067557368590577
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",50328,102,1.30 [0.96-1.75],0.0891008226624584
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,50160,393,0.96 [0.83-1.12],0.6271398242187226
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,50459,173,0.99 [0.79-1.24],0.9474352315873368
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,50249,360,1.01 [0.86-1.18],0.9286528328315689
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of breast,27156,136,0.86 [0.67-1.10],0.2170667588329318
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Leiomyoma of uterus,26655,989,0.98 [0.89-1.07],0.616916432387689
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,47957,385,1.52 [1.31-1.77],6.180981510924234e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,47339,695,1.37 [1.22-1.54],6.918235859953968e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,47339,695,1.37 [1.22-1.54],6.918235859953968e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43597,918,1.32 [1.19-1.46],7.890407123016852e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49433,137,0.99 [0.77-1.28],0.9394408415273018
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,49917,164,0.97 [0.77-1.23],0.8163013107054187
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,40822,2311,1.10 [1.03-1.17],0.0057482273742733
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,47514,1070,1.31 [1.19-1.44],1.8437573955579937e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,45979,270,2.17 [1.84-2.56],8.205297580852377e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48177,220,1.38 [1.13-1.69],0.001534138058856
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45950,241,2.22 [1.87-2.64],2.120716291243005e-19
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,46810,1101,1.69 [1.53-1.85],1.6715888401650597e-27
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,46775,1066,1.68 [1.53-1.85],1.083288033256506e-26
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,46733,360,1.28 [1.08-1.52],0.0048472688268793
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",46736,356,1.27 [1.07-1.51],0.0057314780687297
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40482,1971,1.07 [0.99-1.15],0.0715161781565161
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",38776,265,1.05 [0.88-1.26],0.5913795623533389
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,40327,1816,1.06 [0.98-1.14],0.1235108514957601
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,38606,95,1.07 [0.79-1.46],0.6474379546413427
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",38678,167,1.35 [1.07-1.70],0.0120843212874769
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,42721,1296,1.14 [1.05-1.24],0.0026826272800293
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",41875,450,1.38 [1.19-1.60],1.5345900592390518e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49722,333,1.39 [1.17-1.64],0.000126375510241
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",49852,242,1.58 [1.31-1.92],2.7330000964464205e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,47028,115,1.26 [0.95-1.68],0.1069832773944563
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",50327,115,1.21 [0.91-1.60],0.1836852776586374
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",41540,115,1.26 [0.95-1.68],0.1064714709325937
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Alcohol dependence,47047,134,1.91 [1.50-2.45],2.032668210437745e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,46944,117,1.42 [1.07-1.88],0.0141175584549739
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41527,102,1.25 [0.92-1.69],0.1504004296900917
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",42076,651,1.07 [0.95-1.21],0.2660054375884886
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Depression,47375,568,1.05 [0.93-1.19],0.4252076354288741
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Depression or dysthymia,41568,496,1.07 [0.94-1.23],0.3063122602101836
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",41675,250,1.00 [0.83-1.21],0.9867763026123372
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Other anxiety disorders,47629,130,0.95 [0.73-1.22],0.6686956246223992
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,43189,2920,1.09 [1.03-1.15],0.0043818798261213
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39200,264,0.85 [0.71-1.02],0.077735491010563
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50224,209,0.84 [0.69-1.03],0.0925310217933081
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,47890,955,1.15 [1.04-1.27],0.0046943057161933
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,47230,295,1.11 [0.93-1.32],0.2428118125879765
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,47096,161,1.32 [1.04-1.68],0.0223157574319001
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",49929,145,1.37 [1.06-1.76],0.0142614348662064
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48869,156,1.12 [0.88-1.42],0.3403730337512519
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,47269,334,1.10 [0.93-1.29],0.2672178898355116
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,49388,255,1.10 [0.91-1.33],0.322775592629335
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48227,1317,1.07 [0.98-1.16],0.1163794884991234
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47149,239,0.94 [0.78-1.14],0.5330947581848977
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47669,759,1.08 [0.97-1.21],0.1504519920118723
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,49920,163,1.24 [0.98-1.57],0.0714470667664068
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,49870,113,1.27 [0.96-1.68],0.0957486762387112
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,49544,236,1.11 [0.91-1.35],0.2924471769373719
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49207,717,1.09 [0.97-1.21],0.1551138655589661
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,48908,418,1.08 [0.94-1.25],0.2829800091346619
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48635,145,1.08 [0.84-1.39],0.5454637577157478
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48727,237,1.01 [0.83-1.23],0.9198166346487104
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48641,151,0.93 [0.73-1.18],0.569582259719532
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,43504,314,1.01 [0.85-1.19],0.9381768603401892
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,43969,779,1.18 [1.06-1.32],0.0022672985713477
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,48528,426,1.24 [1.07-1.43],0.0041887503952468
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49855,104,2.17 [1.69-2.80],1.9522185148027536e-09
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4287,104,1.80 [1.37-2.37],3.060403934069973e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",45672,104,2.32 [1.80-2.99],1.0932807837570656e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,49171,182,1.07 [0.86-1.33],0.5712255303233056
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49091,102,1.27 [0.94-1.70],0.1186628527773423
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",49148,169,0.84 [0.67-1.04],0.1098959192822131
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49427,194,1.03 [0.83-1.27],0.8124007923158445
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,50307,256,1.18 [0.98-1.42],0.0814932918647883
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,48808,198,1.14 [0.92-1.41],0.2315087683714189
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,35791,6450,1.20 [1.15-1.26],3.4867024761132425e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,49260,136,1.37 [1.06-1.78],0.0151720264684395
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",37668,4444,1.22 [1.16-1.29],2.9816538834058865e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,37735,4511,1.23 [1.17-1.30],2.834688943257767e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33381,157,2.01 [1.61-2.51],9.593479012549444e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",46173,2355,1.08 [1.02-1.16],0.0159311715070228
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,45230,1412,1.07 [0.98-1.16],0.1229247235220692
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48448,478,1.14 [1.00-1.31],0.0564705585541313
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,48914,944,1.11 [1.01-1.23],0.0349069125596395
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50252,191,1.11 [0.90-1.38],0.3430247627384016
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44402,584,1.11 [0.98-1.25],0.1112822925658171
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,45651,1868,1.08 [1.00-1.16],0.0432817755337666
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,48870,211,1.23 [1.00-1.51],0.0517268913457635
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,49082,441,1.35 [1.17-1.56],4.547209656106968e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,48836,177,1.25 [1.00-1.57],0.0531005284157416
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,48838,179,1.27 [1.02-1.59],0.0362004574934553
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33394,170,1.29 [1.03-1.63],0.0298055075850183
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41873,117,1.00 [0.76-1.32],0.9815502780757434
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,42000,244,1.19 [0.99-1.45],0.0693854030322091
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,27897,232,1.18 [0.96-1.44],0.1071282611974959
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,28544,879,1.33 [1.20-1.48],1.2869270480307192e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,41889,133,1.11 [0.86-1.44],0.4189332440252289
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,41938,182,1.34 [1.07-1.67],0.0100102983343149
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",48397,409,1.42 [1.23-1.65],2.5022758665355896e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",48728,311,1.38 [1.17-1.63],0.000176543764307
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",48795,264,1.35 [1.13-1.62],0.0011778306969079
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",48946,233,1.35 [1.11-1.64],0.0023747041031477
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48172,154,1.15 [0.91-1.47],0.2452298307347529
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48272,254,1.24 [1.03-1.50],0.0227833791233648
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47614,273,1.45 [1.21-1.74],5.667231620701472e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47574,233,1.50 [1.24-1.83],4.542669870351051e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50078,222,1.49 [1.22-1.82],7.59248143251144e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,48275,934,1.11 [1.00-1.23],0.0420264933893067
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,48127,173,1.46 [1.16-1.83],0.0012082450232826
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40271,4052,1.18 [1.13-1.25],5.991606190935919e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50136,215,1.16 [0.94-1.42],0.158951677980728
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,46817,445,1.29 [1.11-1.49],0.0006029807393911
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",46760,388,1.27 [1.09-1.48],0.0027190074583954
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,48656,495,1.17 [1.02-1.34],0.0235976652399326
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,48646,485,1.17 [1.02-1.34],0.0283913701687391
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,48924,1208,1.12 [1.02-1.22],0.0140597745801013
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,47899,183,1.27 [1.02-1.59],0.0342625878087433
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,47962,246,1.23 [1.01-1.49],0.0351141168542718
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48497,781,1.07 [0.96-1.20],0.1905170477687572
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,48083,367,1.02 [0.87-1.19],0.815218079751474
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23220,124,1.20 [0.91-1.58],0.1899407810201093
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,45128,1976,1.10 [1.03-1.18],0.0060307526655786
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,48179,349,1.41 [1.20-1.65],2.6025443895065832e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",48230,400,1.35 [1.17-1.57],6.966110649309412e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",48230,400,1.35 [1.17-1.57],6.966110649309412e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",47110,1632,1.03 [0.96-1.11],0.4070203363932057
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Asthma,36040,1632,1.09 [1.01-1.18],0.027231050933971
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",35512,1632,1.10 [1.01-1.18],0.0214961637160478
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",36015,1607,1.09 [1.01-1.18],0.0347605807401841
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,49773,178,1.41 [1.13-1.76],0.0023755559363692
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,47602,136,1.50 [1.17-1.93],0.0014459049866146
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",49928,136,1.49 [1.16-1.92],0.0019338146064405
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47588,122,1.59 [1.22-2.07],0.0005120273149477
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,46423,218,1.28 [1.04-1.57],0.0176180108406471
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,46674,469,1.38 [1.20-1.59],5.715835785667259e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,48015,214,1.54 [1.26-1.88],2.356244794545963e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34349,11420,1.16 [1.12-1.20],5.258823788228536e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49462,815,1.04 [0.94-1.16],0.4490641151722894
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50447,179,1.03 [0.82-1.29],0.7786870249572913
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,50455,165,1.04 [0.82-1.31],0.7731058427538711
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,48853,206,1.05 [0.85-1.29],0.6426973169535661
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48844,197,1.15 [0.93-1.42],0.2076327667022456
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50429,199,0.97 [0.78-1.19],0.7534625006215454
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48836,189,1.23 [0.99-1.53],0.0651251720163444
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48312,151,1.14 [0.90-1.46],0.2808192284670362
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50287,101,1.08 [0.81-1.46],0.5934400458218181
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38400,534,1.27 [1.11-1.44],0.0003191312479197
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",42111,4245,1.15 [1.10-1.21],1.083049840840816e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,38533,667,1.14 [1.01-1.28],0.0326097973981402
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39222,1356,1.11 [1.02-1.20],0.0168412587523994
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38014,148,1.05 [0.82-1.34],0.7208750154800152
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38272,406,1.20 [1.04-1.40],0.0156122978882909
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,37981,115,1.52 [1.16-2.00],0.0026513864287417
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,38164,298,1.24 [1.05-1.48],0.0137043612024201
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,38110,244,1.39 [1.15-1.67],0.0007686364640268
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50236,170,1.41 [1.13-1.77],0.0027911732812737
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,38107,241,1.28 [1.05-1.55],0.012366482058449
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),39467,1601,1.20 [1.11-1.29],4.999763489096435e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,50196,251,0.98 [0.81-1.18],0.7936686543482776
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,38729,863,1.12 [1.01-1.24],0.0367596339369144
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38202,336,1.04 [0.89-1.23],0.6084516666353177
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50194,307,1.16 [0.98-1.38],0.0921622333091494
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,50146,201,0.97 [0.79-1.20],0.8027946614906938
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,44180,3192,1.06 [1.00-1.12],0.0411467171685783
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,42167,1179,0.96 [0.88-1.05],0.4190450316861838
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,41242,254,1.18 [0.98-1.42],0.0879553328868347
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,41191,203,1.17 [0.95-1.44],0.1448338400930315
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,42676,1688,1.10 [1.02-1.19],0.010833873243035
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48603,1485,1.29 [1.19-1.40],3.4032060219818523e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,39556,3948,1.14 [1.08-1.20],7.767180606199986e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49837,116,1.87 [1.46-2.40],6.944541905494994e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",50372,160,1.81 [1.45-2.25],1.02469988391948e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,47278,160,1.84 [1.47-2.29],6.100024724966329e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47239,121,2.13 [1.68-2.70],3.484428985004366e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",50244,272,1.32 [1.10-1.59],0.0024896817764451
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,47390,272,1.34 [1.12-1.61],0.0015754627826283
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47362,244,1.38 [1.14-1.67],0.0010419223221678
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48319,1201,1.27 [1.16-1.38],1.79682050009795e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48305,1187,1.28 [1.17-1.40],8.620449105107728e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,35797,189,1.07 [0.86-1.33],0.5289797663761433
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal stricture,49594,189,1.04 [0.84-1.30],0.6970582064578468
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",35734,126,1.17 [0.90-1.53],0.2398354761276414
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36798,1190,1.12 [1.02-1.22],0.0148922410077721
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,35929,321,1.02 [0.87-1.21],0.7862999406612247
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,36173,565,1.25 [1.10-1.42],0.0006247603903527
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,47293,507,1.21 [1.06-1.39],0.0050494324916922
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,49622,175,1.30 [1.04-1.63],0.0232945053883878
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35889,281,1.13 [0.94-1.35],0.1983679572300544
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35749,141,1.51 [1.19-1.93],0.0008104104121717
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,37352,1744,1.09 [1.01-1.17],0.0191457765964473
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,36150,542,1.32 [1.16-1.50],2.6475943084738232e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,49593,146,1.28 [1.00-1.64],0.0526200874960333
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,48908,240,2.20 [1.86-2.61],4.4739568501462573e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,48801,133,1.87 [1.47-2.36],2.2766072230087173e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",47816,1226,1.16 [1.07-1.27],0.0006528741990124
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,47573,983,1.13 [1.03-1.25],0.0107889359207583
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,46785,195,1.31 [1.05-1.62],0.0151376765227374
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46691,101,1.37 [1.02-1.85],0.0371715244568153
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,46725,135,1.41 [1.09-1.82],0.0082738468599614
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),50161,135,1.39 [1.08-1.79],0.011598313955085
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,47769,613,1.36 [1.20-1.54],7.685720624481097e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47294,138,1.29 [1.00-1.67],0.0539432371931519
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,47269,113,1.43 [1.08-1.90],0.0129680305507305
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47251,95,1.45 [1.07-1.96],0.0164039253195635
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,47547,391,1.32 [1.13-1.53],0.0004121371937223
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,47533,377,1.34 [1.15-1.57],0.0001946122141627
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,44285,3054,1.10 [1.04-1.17],0.0007627929863205
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,49606,200,0.99 [0.81-1.23],0.9612515314580756
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49681,890,1.02 [0.93-1.13],0.659100579038564
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,47343,1140,1.10 [1.01-1.21],0.0307862731356634
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,48723,777,1.13 [1.01-1.26],0.0299723568254719
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48121,175,1.08 [0.86-1.36],0.4953488924629099
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,48442,496,1.15 [1.01-1.32],0.037527504977341
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,49954,178,1.56 [1.25-1.93],6.830951318149293e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,49914,138,1.71 [1.34-2.17],1.26037796978968e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49880,104,1.59 [1.20-2.11],0.0011529431817383
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,49920,113,0.81 [0.62-1.05],0.1174538162729164
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,49915,108,0.84 [0.64-1.10],0.2032069423870998
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48905,114,0.82 [0.63-1.07],0.1422454367614415
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49499,708,1.03 [0.92-1.15],0.5935069846361439
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46386,183,0.91 [0.73-1.12],0.3670709956140494
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46400,197,1.23 [0.99-1.52],0.0650942086031666
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46352,149,1.19 [0.93-1.53],0.1696147785313472
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46632,429,1.05 [0.91-1.22],0.4940990207482478
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46586,383,1.09 [0.93-1.27],0.2725157978466609
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36385,7834,1.08 [1.04-1.13],7.113601555178174e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39549,4550,1.09 [1.04-1.15],0.0002821538142315
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,45528,2379,1.02 [0.95-1.08],0.6273067928500577
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35298,299,1.68 [1.41-1.99],3.527903805694722e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35910,911,1.32 [1.19-1.46],9.92244787878868e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",49677,287,1.63 [1.37-1.93],2.9520133673780016e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,49697,259,1.69 [1.41-2.02],1.0443167098282392e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37252,2253,1.09 [1.02-1.17],0.0078662215615047
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",42320,2253,1.07 [1.00-1.15],0.0353944608685544
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35137,138,1.11 [0.86-1.43],0.4049371831668031
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",49367,135,1.13 [0.88-1.46],0.3485593396424932
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,35430,431,1.16 [1.00-1.35],0.0463540631529596
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,35142,143,0.85 [0.68-1.07],0.1729871151059879
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,35547,548,1.10 [0.97-1.26],0.1369177856562109
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50191,271,1.02 [0.85-1.23],0.803718346941942
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,36041,1042,1.07 [0.98-1.18],0.1427814576901405
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35772,773,1.15 [1.03-1.29],0.0123733136100973
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,37534,2535,1.04 [0.98-1.11],0.1961420832639142
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35126,127,0.88 [0.68-1.14],0.339967393019838
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35466,467,1.09 [0.95-1.26],0.2099114511892378
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35110,111,1.05 [0.79-1.40],0.7412779997598746
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35117,118,0.84 [0.64-1.10],0.2016389140313963
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,35953,954,0.93 [0.84-1.02],0.1181737855154489
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35824,825,0.90 [0.81-1.00],0.0473445270879217
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39078,549,1.23 [1.08-1.40],0.0017624007141785
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49417,252,1.52 [1.26-1.84],1.2549530515539493e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49275,110,1.47 [1.11-1.96],0.0077111621948558
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,43642,119,1.11 [0.84-1.46],0.4558961913669581
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,44101,578,1.08 [0.95-1.22],0.2218414955841855
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,45342,1819,0.99 [0.92-1.06],0.7275532858950178
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,43892,369,1.07 [0.91-1.24],0.4265406374616133
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,43689,166,1.08 [0.86-1.36],0.5288284714645874
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",44959,1436,0.96 [0.89-1.04],0.2927160199393668
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43623,100,0.84 [0.63-1.12],0.2367834486223083
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,43984,461,0.95 [0.83-1.09],0.4871338256364709
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43723,200,0.95 [0.77-1.17],0.6051495113317573
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43679,156,0.98 [0.77-1.24],0.8706182668334504
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,43799,276,1.03 [0.86-1.24],0.7104591423858336
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43646,123,1.10 [0.84-1.44],0.5090303254053257
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44132,609,0.96 [0.85-1.09],0.5516354607577617
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,43764,615,1.11 [0.98-1.25],0.0972666995550412
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43281,132,1.32 [1.02-1.71],0.0382979534145391
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43319,170,1.16 [0.92-1.46],0.2207218261919229
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43353,204,0.91 [0.74-1.12],0.3793321911244288
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43248,99,0.95 [0.70-1.28],0.7237266587824291
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43375,226,0.90 [0.74-1.09],0.2792987533556439
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43348,199,0.88 [0.72-1.08],0.2310647261014625
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,43664,515,1.02 [0.89-1.16],0.7627820509294236
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43254,105,0.81 [0.62-1.07],0.1346907480029895
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43300,151,1.06 [0.83-1.35],0.639569192343085
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43394,245,1.03 [0.85-1.25],0.7551628644754765
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43271,122,1.14 [0.86-1.49],0.3626491179228271
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",44027,878,0.98 [0.89-1.09],0.750528393275495
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,43477,328,1.09 [0.93-1.29],0.2839190501927676
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,43617,468,0.93 [0.81-1.07],0.3185123016825357
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,46798,339,1.10 [0.93-1.29],0.2684770851151158
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,47227,768,1.12 [1.00-1.25],0.0443035093790484
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46557,98,1.37 [1.01-1.86],0.0405912401869765
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46575,116,0.95 [0.72-1.25],0.7190071956882107
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46660,201,1.12 [0.90-1.38],0.3136296249255417
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,40073,8373,1.09 [1.05-1.14],3.3578185265781147e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20072,1257,1.05 [0.96-1.14],0.3048743658266957
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,45329,503,1.79 [1.57-2.04],2.7472124745330813e-18
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,44962,136,1.50 [1.16-1.94],0.0020405639274695
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,45523,107,1.68 [1.27-2.22],0.0003067508756631
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,45556,140,2.40 [1.94-2.97],1.0426435053624949e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45548,132,2.42 [1.95-3.01],2.0563443368682362e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49780,485,1.10 [0.96-1.25],0.1903305293338811
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,49614,143,1.27 [0.99-1.62],0.0633486284791782
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49644,349,1.13 [0.97-1.33],0.1233993394641472
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49461,166,0.87 [0.70-1.09],0.2366215895384833
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,46126,2067,1.13 [1.06-1.21],0.0003822738554735
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,44254,195,1.17 [0.94-1.45],0.154465398025032
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44217,158,1.20 [0.94-1.52],0.1423337720165513
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,44606,547,1.10 [0.97-1.25],0.1355737718082327
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44284,225,1.00 [0.82-1.22],0.9886816735165458
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,45400,1341,1.17 [1.08-1.28],0.0002130860908631
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19373,558,1.05 [0.93-1.19],0.4380961503342485
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18919,104,0.98 [0.73-1.31],0.8817601199403894
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydrocele,18911,96,1.11 [0.82-1.51],0.4819120369409241
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18974,159,1.28 [1.01-1.63],0.0387599318122201
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18971,156,1.06 [0.84-1.34],0.6430144325174366
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19030,215,0.95 [0.77-1.15],0.5812676918731092
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26896,474,0.95 [0.83-1.09],0.4929361735744818
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26570,148,1.04 [0.81-1.33],0.7478916483325878
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26590,168,1.01 [0.80-1.27],0.9626398892182038
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26533,111,0.98 [0.74-1.30],0.9072212599315324
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26843,543,1.02 [0.89-1.16],0.7959233813070734
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26432,132,1.03 [0.79-1.34],0.8288425872782258
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26539,239,1.01 [0.83-1.22],0.9548732282005844
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24803,4518,0.98 [0.94-1.03],0.5357853596847447
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Endometriosis,20642,357,1.11 [0.95-1.31],0.202136735488928
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20381,96,0.96 [0.71-1.31],0.8107044869202271
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20449,164,1.14 [0.90-1.45],0.269713307396482
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21061,776,0.98 [0.88-1.10],0.7711591732995426
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20687,402,1.06 [0.91-1.23],0.4441828066184313
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21226,941,0.95 [0.86-1.05],0.3310529300813852
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20598,313,0.93 [0.79-1.10],0.3761435851831588
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20715,430,1.17 [1.01-1.35],0.0418616198892926
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20381,96,1.25 [0.91-1.71],0.1618636329628809
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20468,183,1.05 [0.84-1.31],0.6633601571530414
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27171,260,1.07 [0.89-1.30],0.4642927540389443
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27182,246,1.09 [0.89-1.32],0.4094817906936771
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27208,136,1.00 [0.77-1.29],0.9926108154202616
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27198,150,1.00 [0.78-1.27],0.9688805044909884
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20429,144,1.08 [0.84-1.39],0.526525026053063
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20399,114,0.79 [0.61-1.03],0.0792723090643086
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20424,139,0.88 [0.69-1.12],0.3020237776937445
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Irregular menses,27100,458,1.09 [0.94-1.26],0.2414987432751048
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21602,1317,1.04 [0.95-1.13],0.3712686287280043
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21147,862,1.04 [0.93-1.15],0.5027732955767287
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27187,191,1.07 [0.86-1.33],0.5731568284457096
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20746,461,0.87 [0.76-1.00],0.0477014328145026
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20606,321,1.17 [0.98-1.39],0.0767492312725512
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21173,888,1.01 [0.91-1.12],0.8532425594201323
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female infertility,20396,111,0.95 [0.72-1.27],0.7367024330717967
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20389,104,1.00 [0.74-1.35],0.9945938709945716
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27208,867,1.11 [0.99-1.24],0.0878217287399652
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27210,1182,1.10 [1.00-1.22],0.0594361312786647
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27207,474,1.03 [0.89-1.19],0.7153012380127186
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26868,135,1.02 [0.78-1.33],0.8831563371165279
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26922,189,1.19 [0.95-1.50],0.1343587188618374
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26898,165,0.84 [0.67-1.05],0.1284421977637825
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27225,168,0.80 [0.64-1.01],0.0624611842698821
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27227,165,0.79 [0.63-0.99],0.0427367454736306
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27222,410,1.17 [1.00-1.37],0.0550262859023162
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26937,125,1.06 [0.80-1.40],0.7004723406255315
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27037,225,1.25 [1.01-1.54],0.0420306657013333
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26490,149,0.96 [0.75-1.23],0.7467183834321125
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26539,198,0.94 [0.75-1.17],0.5691869903435117
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26592,251,1.10 [0.90-1.34],0.3655428558936143
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26486,145,1.70 [1.30-2.23],9.134276981601e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26478,137,1.05 [0.81-1.37],0.7140859881454991
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26487,146,0.96 [0.75-1.24],0.7681362683198134
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26257,229,0.93 [0.75-1.14],0.4674759983497936
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26461,433,1.05 [0.90-1.23],0.5195140419911743
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26689,661,1.15 [1.00-1.31],0.042183350109727
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27226,168,1.04 [0.82-1.32],0.7583659924683438
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25793,127,1.06 [0.80-1.40],0.7002934528800582
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26130,102,1.32 [0.96-1.82],0.0844316806110409
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27234,333,1.07 [0.90-1.27],0.4606079667213976
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27155,254,1.07 [0.88-1.31],0.4784445329012143
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27222,250,0.86 [0.71-1.04],0.1183898363603766
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27213,241,0.86 [0.71-1.04],0.1251536772744119
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",49726,120,1.08 [0.83-1.42],0.567900759195423
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,45498,1173,1.14 [1.04-1.24],0.0053852780654908
